Considering the importance and frequency of recurrent chromosomal abnormalities, AML with translocation t(8;21) results in an AML1/ETO fusion gene involved in blocking AML-1 dependent transcription activation. The gene discussed is RUNX1; the disease is acute myeloid leukemia.